FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1

SIMPLE SUMMARY: Current approaches to treat cancer include eg. targeted therapies, employing agents, such as antibodies, aimed directly at molecules expressed in cancerous cells. Here we present a targeting molecule alternative to antibodies-peptibodyF2-composed of a peptide responsible for its targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Jendryczko, Karolina, Chudzian, Julia, Skinder, Natalia, Opaliński, Łukasz, Rzeszótko, Jakub, Wiedlocha, Antoni, Otlewski, Jacek, Szlachcic, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602595/
https://www.ncbi.nlm.nih.gov/pubmed/33076489
http://dx.doi.org/10.3390/cancers12102992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602595/
https://www.ncbi.nlm.nih.gov/pubmed/33076489
http://dx.doi.org/10.3390/cancers12102992

Ejemplares similares